Literature DB >> 21373213

Breast Cancer Guidelines in Canada: A Review of Development and Implementation.

Amy Folkes1, Robin Urquhart, Louise Zitzelsberger, Eva Grunfeld.   

Abstract

A series of specific clinical practice guidelines (CPGs) were published in Canada in 1998. A primary objective of these 'Clinical Practice Guidelines for the Care and Treatment of Breast Cancer' was to decrease the variation in breast cancer care across the country. Prior to this, researchers found moderate compliance with consensus recommendations for breast cancer therapies in several Canadian provinces. However, a recent study concluded that the publication of the Canadian CPGs did not reduce variations in surgical care for breast cancer. If guidelines are to achieve their intended objectives, they must be implemented in ways that support, encourage, and facilitate their use. Evidence strongly suggests the simple publication and passive dissemination of CPGs are usually ineffective in changing how physicians actually care for patients. CPG implementation, therefore, requires active knowledge translation processes to ensure that the evidence is relevant to all with a stake in bettering breast cancer care. For example, implementation strategies that use computerized CPGs can make evidence-based decision-making routine practice in the clinical setting. The breast cancer community can also work with the newly formed Canadian Partnership Against Cancer to find ways to more successfully support and facilitate guideline use considering the local context.

Entities:  

Year:  2008        PMID: 21373213      PMCID: PMC2931084          DOI: 10.1159/000121732

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  31 in total

1.  A toolkit to facilitate the implementation of clinical practice guidelines in healthcare settings.

Authors:  Alba DiCenso; Tazim Virani; Irmajean Bajnok; Elizabeth Borycki; Barbara Davies; Ian Graham; Margaret Harrison; Jo Logan; Lynn McCleary; Michael Power; Julia Scott
Journal:  Hosp Q       Date:  2002

2.  Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).

Authors:  Eva Grunfeld; Sukhbinder Dhesy-Thind; Mark Levine
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

3.  Computerized decision support based on a clinical practice guideline improves compliance with care standards.

Authors:  D F Lobach; W E Hammond
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

4.  A guide to the Canadian Medical Association handbook on clinical practice guidelines.

Authors:  Valerie A Palda; Dave Davis; Joanne Goldman
Journal:  CMAJ       Date:  2007-11-06       Impact factor: 8.262

5.  Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review.

Authors:  D L Hunt; R B Haynes; S E Hanna; K Smith
Journal:  JAMA       Date:  1998-10-21       Impact factor: 56.272

6.  Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study.

Authors:  E G Mansour; R Gray; A H Shatila; C K Osborne; D C Tormey; K W Gilchrist; M R Cooper; G Falkson
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

7.  Compliance with practice guidelines for node-negative breast cancer.

Authors:  A Olivotto; A J Coldman; T G Hislop; C H Trevisan; J Kula; V Goel; C Sawka
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

Review 8.  National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.

Authors: 
Journal:  J Natl Cancer Inst Monogr       Date:  2001

9.  Ontology-based modeling of clinical practice guidelines: a clinical decision support system for breast cancer follow-up interventions at primary care settings.

Authors:  Samina R Abidi; Syed S R Abidi; Sajjad Hussain; Mike Shepherd
Journal:  Stud Health Technol Inform       Date:  2007

10.  A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.

Authors:  B Fisher; C Redmond; N V Dimitrov; D Bowman; S Legault-Poisson; D L Wickerham; N Wolmark; E R Fisher; R Margolese; C Sutherland
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

View more
  2 in total

1.  Factors related to the implementation and use of an innovation in cancer surgery.

Authors:  R Urquhart; J Sargeant; G A Porterm
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative study.

Authors:  Robin Urquhart; Cynthia Kendell; Joan Sargeant; Gordon Buduhan; Paul Johnson; Daniel Rayson; Eva Grunfeld; Geoffrey A Porter
Journal:  Implement Sci       Date:  2012-10-25       Impact factor: 7.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.